These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 10821969)

  • 1. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.
    Tsai TF
    Vaccine; 2000 May; 18 Suppl 2():1-25. PubMed ID: 10821969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergic reactions to Japanese encephalitis vaccine.
    Plesner AM
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japanese encephalitis vaccines: current vaccines and future prospects.
    Monath TP
    Curr Top Microbiol Immunol; 2002; 267():105-38. PubMed ID: 12082985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coverage & missed opportunity for Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2015: Implications for Japanese encephalitis control.
    Murhekar MV; Oak C; Ranjan P; Kanagasabai K; Shinde S; Pandey AK; Mittal M; Gore M; Mehendale SM
    Indian J Med Res; 2017 Jan; 145(1):63-69. PubMed ID: 28574016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese Encephalitis Surveillance and Immunization - Asia and Western Pacific Regions, 2016.
    Heffelfinger JD; Li X; Batmunkh N; Grabovac V; Diorditsa S; Liyanage JB; Pattamadilok S; Bahl S; Vannice KS; Hyde TB; Chu SY; Fox KK; Hills SL; Marfin AA
    MMWR Morb Mortal Wkly Rep; 2017 Jun; 66(22):579-583. PubMed ID: 28594790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO working group on the quality, safety and efficacy of japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21-23 February 2012.
    Trent DW; Minor P; Jivapaisarnpong T; Shin J;
    Biologicals; 2013 Nov; 41(6):450-7. PubMed ID: 23891495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Fischer M; Lindsey N; Staples JE; Hills S;
    MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost benefit analysis of Japanese encephalitis vaccination program in Thailand.
    Siraprapasiri T; Sawaddiwudhipong W; Rojanasuphot S
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):143-8. PubMed ID: 9322297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1993 Jan; 42(RR-1):1-15. PubMed ID: 8381504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese encephalitis surveillance and immunization--Asia and the Western Pacific, 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(33):658-62. PubMed ID: 23965828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
    Zhou B; Jia L; Xu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains.
    Kurane I; Takasaki T
    Vaccine; 2000 May; 18 Suppl 2():33-5. PubMed ID: 10821971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current recommendations for the Japanese encephalitis vaccine.
    Chen HL; Chang JK; Tang RB
    J Chin Med Assoc; 2015 May; 78(5):271-5. PubMed ID: 25841620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.
    Ginsburg AS; Meghani A; Halstead SB; Yaich M
    Hum Vaccin Immunother; 2017 Oct; 13(10):2222-2231. PubMed ID: 28841362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive strategies for frequent outbreaks of Japanese encephalitis in Northern India.
    Saxena V; Dhole TN
    J Biosci; 2008 Nov; 33(4):505-14. PubMed ID: 19208976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japanese encephalitis vaccine: need of the hour in endemic states of India.
    Verma R
    Hum Vaccin Immunother; 2012 Apr; 8(4):491-3. PubMed ID: 22370517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
    Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japanese encephalitis immunization in South Korea: past, present, and future.
    Sohn YM
    Emerg Infect Dis; 2000; 6(1):17-24. PubMed ID: 10653564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children.
    Chanthavanich P; Limkittikul K; Sirivichayakul C; Chokejindachai W; Hattasingh W; Pengsaa K; Surangsrirat S; Srisuwannaporn T; Kaewma B; Yoksan S; Jun G; Zhumu B
    Hum Vaccin Immunother; 2018 Apr; 14(4):900-905. PubMed ID: 29227177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and control of Japanese encephalitis.
    Igarashi A
    World Health Stat Q; 1992; 45(2-3):299-305. PubMed ID: 1334301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.